Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 386

1.

The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries.

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A.

Int J Tuberc Lung Dis. 2019 Nov 1;23(11):1131-1141. doi: 10.5588/ijtld.19.0397.

PMID:
31718748
2.

COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.

Lowe KE, Regan EA, Anzueto A, Austin E, Austin JHM, Beaty TH, Benos PV, Benway CJ, Bhatt SP, Bleecker ER, Bodduluri S, Bon J, Boriek AM, Boueiz AR, Bowler RP, Budoff M, Casaburi R, Castaldi PJ, Charbonnier JP, Cho MH, Comellas A, Conrad D, Costa Davis C, Criner GJ, Curran-Everett D, Curtis JL, DeMeo DL, Diaz AA, Dransfield MT, Dy JG, Fawzy A, Fleming M, Flenaugh EL, Foreman MG, Fortis S, Gebrekristos H, Grant S, Grenier PA, Gu T, Gupta A, Han MK, Hanania NA, Hansel NN, Hayden LP, Hersh CP, Hobbs BD, Hoffman EA, Hogg JC, Hokanson JE, Hoth KF, Hsiao A, Humphries S, Jacobs K, Jacobson FL, Kazerooni EA, Kim V, Kim WJ, Kinney GL, Koegler H, Lutz SM, Lynch DA, MacIntye NR Jr, Make BJ, Marchetti N, Martinez FJ, Maselli DJ, Mathews AM, McCormack MC, McDonald MN, McEvoy CE, Moll M, Molye SS, Murray S, Nath H, Newell JD Jr, Occhipinti M, Paoletti M, Parekh T, Pistolesi M, Pratte KA, Putcha N, Ragland M, Reinhardt JM, Rennard SI, Rosiello RA, Ross JC, Rossiter HB, Ruczinski I, San Jose Estepar R, Sciurba FC, Sieren JC, Singh H, Soler X, Steiner RM, Strand MJ, Stringer WW, Tal-Singer R, Thomashow B, Vegas Sánchez-Ferrero G, Walsh JW, Wan ES, Washko GR, Michael Wells J, Wendt CH, Westney G, Wilson A, Wise RA, Yen A, Young K, Yun J, Silverman EK, Crapo JD.

Chronic Obstr Pulm Dis. 2019 Nov;6(5):384-399. doi: 10.15326/jcopdf.6.5.2019.0149.

3.

Endobronchial removal of uncovered stent using argon plasma coagulation via fibreoptic bronchoscopy.

Zantah M, Basile M, Burtulato M, Criner GJ.

Respirol Case Rep. 2019 Oct 22;7(9):e00496. doi: 10.1002/rcr2.496. eCollection 2019 Dec.

4.

Metoprolol for the Prevention of Acute Exacerbations of COPD.

Dransfield MT, Voelker H, Bhatt SP, Brenner K, Casaburi R, Come CE, Cooper JAD, Criner GJ, Curtis JL, Han MK, Hatipoğlu U, Helgeson ES, Jain VV, Kalhan R, Kaminsky D, Kaner R, Kunisaki KM, Lambert AA, Lammi MR, Lindberg S, Make BJ, Martinez FJ, McEvoy C, Panos RJ, Reed RM, Scanlon PD, Sciurba FC, Smith A, Sriram PS, Stringer WW, Weingarten JA, Wells JM, Westfall E, Lazarus SC, Connett JE; BLOCK COPD Trial Group.

N Engl J Med. 2019 Oct 20. doi: 10.1056/NEJMoa1908142. [Epub ahead of print]

PMID:
31633896
5.

Reply to: Improving Lung Function in Severe Heterogenous Emphysema... Still a Great Need to "EMPROVE".

Criner GJ; all authors of “Improving Lung Function in Severe Heterogenous Emphysema with the Spiration® Valve System (EMPROVE): A Multicenter, Open-Label, Randomized, Controlled Trial.”.

Am J Respir Crit Care Med. 2019 Oct 3. doi: 10.1164/rccm.201909-1798LE. [Epub ahead of print] No abstract available.

PMID:
31580712
6.

Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies.

Criner GJ, Celli BR, Singh D, Agusti A, Papi A, Jison M, Makulova N, Shih VH, Brooks L, Barker P, Martin UJ, Newbold P.

Lancet Respir Med. 2019 Sep 27. pii: S2213-2600(19)30338-8. doi: 10.1016/S2213-2600(19)30338-8. [Epub ahead of print]

PMID:
31575508
7.

Mortality for sarcoidosis patients on the transplant wait list in the Lung Allocation Score era: Experience from a high volume center.

Gangemi AJ, Myers CN, Zheng M, Brown J, Butler-LeBair M, Cordova F, Marchetti N, Criner GJ, Gupta R, Mamary AJ.

Respir Med. 2019 Oct;157:69-76. doi: 10.1016/j.rmed.2019.09.001. Epub 2019 Sep 7.

PMID:
31522032
8.

Misinterpretation of time-to-first event curves can lead to inappropriate treatment.

Hartley B, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Jones CE, Kilbride S, Lange P, Lipson DA, Lomas DA, Martin N, Martinez FJ, Singh D, Wise RA, Lettis S.

Eur Respir J. 2019 Sep 5;54(3). pii: 1900634. doi: 10.1183/13993003.00634-2019. Print 2019 Sep. No abstract available.

PMID:
31488584
9.

The effect of cysteine oxidation on DJ-1 cytoprotective function in human alveolar type II cells.

Bahmed K, Boukhenouna S, Karim L, Andrews T, Lin J, Powers R, Wilson MA, Lin CR, Messier E, Reisdorph N, Powell RL, Tang HY, Mason RJ, Criner GJ, Kosmider B.

Cell Death Dis. 2019 Sep 2;10(9):638. doi: 10.1038/s41419-019-1833-5.

10.

Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.

Arjomandi M, Zeng S, Barjaktarevic I, Barr RG, Bleecker ER, Bowler RP, Buhr RG, Criner GJ, Comellas AP, Cooper CB, Couper DJ, Curtis JL, Dransfield MT, Han MK, Hansel NN, Hoffman EA, Kaner RJ, Kanner RE, Krishnan JA, Paine R 3rd, Peters SP, Rennard SI, Woodruff PG; SPIROMICS Investigators.

Eur Respir J. 2019 Oct 31;54(4). pii: 1802214. doi: 10.1183/13993003.02214-2018. Print 2019 Oct.

PMID:
31439683
11.

Compartmentalization of anti-oxidant and anti-inflammatory gene expression in current and former smokers with COPD.

Sidhaye VK, Holbrook JT, Burke A, Sudini KR, Sethi S, Criner GJ, Fahey JW, Berenson CS, Jacobs MR, Thimmulappa R, Wise RA, Biswal S.

Respir Res. 2019 Aug 20;20(1):190. doi: 10.1186/s12931-019-1164-1.

12.

Targeting p16-induced senescence prevents cigarette smoke-induced emphysema by promoting IGF1/Akt1 signaling in mice.

Cottage CT, Peterson N, Kearley J, Berlin A, Xiong X, Huntley A, Zhao W, Brown C, Migneault A, Zerrouki K, Criner G, Kolbeck R, Connor J, Lemaire R.

Commun Biol. 2019 Aug 9;2:307. doi: 10.1038/s42003-019-0532-1. eCollection 2019.

13.

Sonographic Evaluation of Diaphragmatic Dysfunction: Technique, Interpretation, and Clinical Applications.

Dass C, Dako F, Simpson S, Marchetti N, Steiner R, Criner G.

J Thorac Imaging. 2019 Nov;34(6):W131-W140. doi: 10.1097/RTI.0000000000000436.

PMID:
31385877
14.

Mitochondrial dysfunction in human primary alveolar type II cells in emphysema.

Kosmider B, Lin CR, Karim L, Tomar D, Vlasenko L, Marchetti N, Bolla S, Madesh M, Criner GJ, Bahmed K.

EBioMedicine. 2019 Aug;46:305-316. doi: 10.1016/j.ebiom.2019.07.063. Epub 2019 Aug 2.

15.

Improving Lung Function in Severe Heterogenous Emphysema with the Spiration® Valve System (EMPROVE): A Multicenter, Open-Label, Randomized, Controlled Trial.

Criner GJ, Delage A, Voelker K, Hogarth DK, Majid A, Zgoda M, Lazarus DR, Casal R, Benzaquen SB, Holladay RC, Wellikoff A, Calero K, Rumbak MJ, Branca PR, Abu-Hijleh M, Mallea JM, Kalhan R, Sachdeva A, Kinsey CM, Lamb CR, Reed MF, Abouzgheib WB, Kaplan PV, Marrujo GX, Johnstone DW, Gasparri MG, Meade AA, Hergott CA, Reddy C, Mularski RA, Case AH, Makani SS, Shepherd RW, Chen B, Holt GE, Martel S; EMPROVE Study Group.

Am J Respir Crit Care Med. 2019 Jul 31. doi: 10.1164/rccm.201902-0383OC. [Epub ahead of print]

PMID:
31365298
16.

The relationship between DJ-1 and S100A8 in human primary alveolar type II cells in emphysema.

Lin CR, Bahmed K, Tomar D, Marchetti N, Criner GJ, Bolla S, Wilson MA, Madesh M, Kosmider B.

Am J Physiol Lung Cell Mol Physiol. 2019 Jul 17. doi: 10.1152/ajplung.00494.2018. [Epub ahead of print]

PMID:
31313618
17.

The role of DJ-1 in human primary alveolar type II cell injury induced by e-cigarette aerosol.

Bahmed K, Lin CR, Simborio H, Karim L, Aksoy M, Kelsen S, Tomar D, Madesh M, Elrod J, Messier E, Mason R, Unterwald EM, Eisenstein TK, Criner GJ, Kosmider B.

Am J Physiol Lung Cell Mol Physiol. 2019 Oct 1;317(4):L475-L485. doi: 10.1152/ajplung.00567.2018. Epub 2019 Jul 17.

PMID:
31313616
18.

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.

Pascoe S, Barnes N, Brusselle G, Compton C, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Hartley B, Lange P, Lettis S, Lipson DA, Lomas DA, Martinez FJ, Papi A, Roche N, van der Valk RJP, Wise R, Singh D.

Lancet Respir Med. 2019 Sep;7(9):745-756. doi: 10.1016/S2213-2600(19)30190-0. Epub 2019 Jul 4.

PMID:
31281061
19.

It is time for the world to take COPD seriously: a statement from the GOLD board of directors.

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A.

Eur Respir J. 2019 Jul 4;54(1). pii: 1900914. doi: 10.1183/13993003.00914-2019. Print 2019 Jul. No abstract available.

PMID:
31273036
20.

Benralizumab for the Prevention of COPD Exacerbations.

Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators.

N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20.

PMID:
31112385
21.

The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.

Kim V, Zhao H, Regan E, Han MK, Make BJ, Crapo JD, Jones PW, Curtis JL, Silverman EK, Criner GJ; COPDGene Investigators.

Chest. 2019 Oct;156(4):685-695. doi: 10.1016/j.chest.2019.03.041. Epub 2019 May 15.

PMID:
31047955
22.

Automatic EPAP intelligent volume-assured pressure support is effective in patients with chronic respiratory failure: A randomized trial.

Orr JE, Coleman J, Criner GJ, Sundar KM, Tsai SC, Benjafield AV, Crocker ME, Willes L, Malhotra A, Owens RL, Wolfe LF.

Respirology. 2019 Dec;24(12):1204-1211. doi: 10.1111/resp.13546. Epub 2019 Apr 22.

PMID:
31012225
23.

Chronic Obstructive Pulmonary Disease: Evaluation and Management.

Duffy SP, Criner GJ.

Med Clin North Am. 2019 May;103(3):453-461. doi: 10.1016/j.mcna.2018.12.005. Epub 2019 Mar 14. Review.

PMID:
30955513
24.

Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study.

Raghu G, Flaherty KR, Lederer DJ, Lynch DA, Colby TV, Myers JL, Groshong SD, Larsen BT, Chung JH, Steele MP, Benzaquen S, Calero K, Case AH, Criner GJ, Nathan SD, Rai NS, Ramaswamy M, Hagmeyer L, Davis JR, Gauhar UA, Pankratz DG, Choi Y, Huang J, Walsh PS, Neville H, Lofaro LR, Barth NM, Kennedy GC, Brown KK, Martinez FJ.

Lancet Respir Med. 2019 Jun;7(6):487-496. doi: 10.1016/S2213-2600(19)30059-1. Epub 2019 Apr 1.

PMID:
30948346
25.

A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography.

Oelsner EC, Ortega VE, Smith BM, Nguyen JN, Manichaikul AW, Hoffman EA, Guo X, Taylor KD, Woodruff PG, Couper DJ, Hansel NN, Martinez FJ, Paine R 3rd, Han MK, Cooper C, Dransfield MT, Criner G, Krishnan JA, Bowler R, Bleecker ER, Peters S, Rich SS, Meyers DA, Rotter JI, Barr RG.

Am J Respir Crit Care Med. 2019 Sep 15;200(6):721-731. doi: 10.1164/rccm.201812-2355OC.

PMID:
30925230
26.

Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.

Fortis S, Comellas A, Make BJ, Hersh CP, Bodduluri S, Georgopoulos D, Kim V, Criner GJ, Dransfield MT, Bhatt SP; COPDGene Investigators–Core Units: <italic>Administrative Center</italic>, COPDGene Investigators–Clinical Centers: <italic>Ann Arbor VA</italic>.

Ann Am Thorac Soc. 2019 Jul;16(7):826-835. doi: 10.1513/AnnalsATS.201809-601OC.

PMID:
30908927
27.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M, López Varela MV, Martinez F, Montes de Oca M, Papi A, Pavord ID, Roche N, Sin DD, Stockley R, Vestbo J, Wedzicha JA, Vogelmeier C.

Eur Respir J. 2019 May 18;53(5). pii: 1900164. doi: 10.1183/13993003.00164-2019. Print 2019 May. Review.

PMID:
30846476
28.

Endoscopic Lung Volume Reduction: An Expert Panel Recommendation - Update 2019.

Herth FJF, Slebos DJ, Criner GJ, Valipour A, Sciurba F, Shah PL.

Respiration. 2019;97(6):548-557. doi: 10.1159/000496122. Epub 2019 Mar 5.

PMID:
30836374
29.

Effect of daily azithromycin therapy and adherence on readmission risk in COPD.

Krishnan JK, Voelker H, Connett JE, Niewoehner DE, Albert RK, Scanlon PD, Criner GJ, Dransfield MT, Han MK, Martinez FJ; COPD Clinical Research Network Investigators.

Eur Respir J. 2019 Mar 18;53(3). pii: 1801377. doi: 10.1183/13993003.01377-2018. Print 2019 Mar. No abstract available.

PMID:
30819817
30.

Characteristics at the time of oxygen initiation associated with its adherence: Findings from the COPD Long-term Oxygen Treatment Trial.

Moy ML, Harrington KF, Sternberg AL, Krishnan JA, Albert RK, Au DH, Casaburi R, Criner GJ, Diaz P, Kanner RE, Panos RJ, Stibolt T, Stoller JK, Tonascia J, Yusen RD, Tan AM, Fuhlbrigge AL; LOTT Research Group.

Respir Med. 2019 Mar;149:52-58. doi: 10.1016/j.rmed.2019.02.004. Epub 2019 Feb 13.

PMID:
30803886
31.

Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema.

Slebos DJ, Cicenia J, Sciurba FC, Criner GJ, Hartman JE, Garner J, Deslée G, Delage A, Jantz M, Marquette CH, Strange C, Hatipoglu U, Mehta AC, LaPrad AS, Schmid-Bindert G, Herth FJF, Shah PL; RENEW Study Group.

Chest. 2019 May;155(5):928-937. doi: 10.1016/j.chest.2019.02.012. Epub 2019 Feb 21.

PMID:
30797746
32.

Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary Disease.

Vasilescu DM, Martinez FJ, Marchetti N, Galbán CJ, Hatt C, Meldrum CA, Dass C, Tanabe N, Reddy RM, Lagstein A, Ross BD, Labaki WW, Murray S, Meng X, Curtis JL, Hackett TL, Kazerooni EA, Criner GJ, Hogg JC, Han MK.

Am J Respir Crit Care Med. 2019 Sep 1;200(5):575-581. doi: 10.1164/rccm.201811-2083OC.

PMID:
30794432
33.

Effects of Roflumilast on Rehospitalization and Mortality in Patients.

Criner GJ, Jacobs MR, Zhao H, Marchetti N.

Chronic Obstr Pulm Dis. 2018 Dec 20;6(1):74-85. doi: 10.15326/jcopdf.6.1.2018.0139.

34.

Patient Preferences for Endobronchial Valve Treatment of Severe Emphysema.

Mansfield C, Sutphin J, Shriner K, Criner GJ, Celli BR.

Chronic Obstr Pulm Dis. 2018 Dec 11;6(1):51-63. doi: 10.15326/jcopdf.6.1.2018.0147.

35.

Effect of Lung Volume Reduction Surgery on Respiratory Muscle Strength in Advanced Emphysema.

Criner RN, Yu D, Jacobs MR, Criner GJ.

Chronic Obstr Pulm Dis. 2018 Oct 12;6(1):40-50. doi: 10.15326/jcopdf.6.1.2018.0188.

36.

Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study.

Papi A, Zheng J, Criner GJ, Fabbri LM, Calverley PMA.

Respir Med. 2019 Feb;147:37-43. doi: 10.1016/j.rmed.2018.12.014. Epub 2019 Jan 9.

PMID:
30704697
37.

Impaired non-homologous end joining in human primary alveolar type II cells in emphysema.

Kosmider B, Lin CR, Vlasenko L, Marchetti N, Bolla S, Criner GJ, Messier E, Reisdorph N, Powell RL, Madesh M, Kelsen S, Xander N, Correll KA, Mason RJ, Bahmed K.

Sci Rep. 2019 Jan 29;9(1):920. doi: 10.1038/s41598-018-37000-z.

38.

Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.

Garudadri S, Woodruff PG, Han MK, Curtis JL, Barr RG, Bleecker ER, Bowler RP, Comellas A, Cooper CB, Criner G, Dransfield MT, Hansel NN, Paine R 3rd, Krishnan JA, Peters SP, Hastie AT, Martinez FJ, O'Neal WK, Couper DJ, Alexis NE, Christenson SA.

Chest. 2019 May;155(5):908-917. doi: 10.1016/j.chest.2018.12.022. Epub 2019 Jan 23.

PMID:
30684474
39.

Temporary transvenous diaphragm pacing vs. standard of care for weaning from mechanical ventilation: study protocol for a randomized trial.

Evans D, Shure D, Clark L, Criner GJ, Dres M, de Abreu MG, Laghi F, McDonagh D, Petrof B, Nelson T, Similowski T.

Trials. 2019 Jan 17;20(1):60. doi: 10.1186/s13063-018-3171-9.

40.

Using the Peripheral Blood Eosinophil Count to Manage Patients with Chronic Obstructive Pulmonary Disease.

Celli BR, Criner GJ.

Ann Am Thorac Soc. 2019 Mar;16(3):301-303. doi: 10.1513/AnnalsATS.201810-729PS. No abstract available.

PMID:
30620613
41.

Race and Gender Disparities are Evident in COPD Underdiagnoses Across all Severities of Measured Airflow Obstruction.

Mamary AJ, Stewart JI, Kinney GL, Hokanson JE, Shenoy K, Dransfield MT, Foreman MG, Vance GB, Criner GJ; COPDGene® Investigators.

Chronic Obstr Pulm Dis. 2018 Jul 2;5(3):177-184. doi: 10.15326/jcopdf.5.3.2017.0145.

42.

Clinical Differences in COPD Patients with Variable Patterns of Hypoxemia.

Narewski ER, Blackford AL, Lammi MR, Fuhlbrigge AL, Soler X, Albert R, Criner GJ; Long-Term Oxygen Treatment Trial Research Group.

Chronic Obstr Pulm Dis. 2018 Apr 28;5(3):167-176. doi: 10.15326/jcopdf.5.3.2017.0175.

43.

Mepolizumab for the prevention of chronic obstructive pulmonary disease exacerbations.

Fernandez Romero GA, Beros J, Criner G.

Expert Rev Respir Med. 2019 Feb;13(2):125-132. doi: 10.1080/17476348.2019.1561287. Epub 2018 Dec 30. Review.

PMID:
30570418
44.

Let's Call It Lung Shock - Or Do We Use the Right Wording?

Herth FJF, Sorichter S, Criner GJ.

Respiration. 2019;97(3):197-198. doi: 10.1159/000495256. Epub 2018 Dec 12. No abstract available.

PMID:
30540992
45.

A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.

Kossenkov AV, Qureshi R, Dawany NB, Wickramasinghe J, Liu Q, Majumdar RS, Chang C, Widura S, Kumar T, Horng WH, Konnisto E, Criner G, Tsay JJ, Pass H, Yendamuri S, Vachani A, Bauer T, Nam B, Rom WN, Showe MK, Showe LC.

Cancer Res. 2019 Jan 1;79(1):263-273. doi: 10.1158/0008-5472.CAN-18-2032. Epub 2018 Nov 28.

PMID:
30487137
46.

Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee.

Criner GJ, Martinez FJ, Aaron S, Agusti A, Anzueto A, Bafadhel M, Barnes PJ, Bourbeau J, Chen R, Ewig J, Fabbri LM, Frith P, Halpin DMG, Han M, Montes de Oca M, Nishimura M, O'Donnell D, Papi A, Pavord I, Roche N, Rodriguez-Roisin R, Salvi S, Singh D, Sin DD, Stockley R, López Varela MV, Vestbo J, Vogelmeier CF, Washko G, Wedzicha JA, Celli BR.

Ann Am Thorac Soc. 2019 Jan;16(1):29-39. doi: 10.1513/AnnalsATS.201808-557PS. No abstract available.

PMID:
30427736
47.

Inflammatory signature in lung tissues in patients with combined pulmonary fibrosis and emphysema.

Cornwell WD, Kim C, Lastra AC, Dass C, Bolla S, Wang H, Zhao H, Ramsey FV, Marchetti N, Rogers TJ, Criner GJ.

Biomarkers. 2019 May;24(3):232-239. doi: 10.1080/1354750X.2018.1542458. Epub 2018 Nov 19.

PMID:
30411980
48.

Markers of Dental Health Correlate with Daily Respiratory Symptoms in COPD.

Gaeckle NT, Heyman B, Criner AJ, Criner GJ.

Chronic Obstr Pulm Dis. 2018 Apr 1;5(2):97-105. doi: 10.15326/jcopdf.5.2.2017.0159.

49.

Endobronchial Coils Versus Lung Volume Reduction Surgery or Medical Therapy for Treatment of Advanced Homogenous Emphysema.

Marchetti N, Kaufman T, Chandra D, Herth FJ, Shah PL, Slebos DJ, Dass C, Bicknell S, Blaas SH, Pfeifer M, Stanzell F, Witt C, Deslee G, Gesierich W, Hetzel M, Kessler R, Leroy S, Hetzel J, Sciurba FC, Criner GJ.

Chronic Obstr Pulm Dis. 2018 Apr 1;5(2):87-96. doi: 10.15326/jcopdf.5.2.2017.0134.

50.

Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease.

Seo M, Qiu W, Bailey W, Criner GJ, Dransfield MT, Fuhlbrigge AL, Reilly JJ, Scholand MB, Castaldi P, Chase R, Parker M, Saferali A, Yun JH, Crapo JD, Cho MH, Beaty TH, Silverman EK, Hersh CP.

J Mol Med (Berl). 2018 Dec;96(12):1375-1385. doi: 10.1007/s00109-018-1708-8. Epub 2018 Oct 23.

PMID:
30353303

Supplemental Content

Loading ...
Support Center